These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 19948239

  • 1. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F.
    Nitric Oxide; 2010 Jan 01; 22(1):43-50. PubMed ID: 19948239
    [Abstract] [Full Text] [Related]

  • 2. Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells.
    Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, Parveen S, Nikonoff LE, Kots AY, Murad F.
    Proc Natl Acad Sci U S A; 2008 Dec 02; 105(48):18924-9. PubMed ID: 19020077
    [Abstract] [Full Text] [Related]

  • 3. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
    El-Sehemy A, Chang AC, Azad AK, Gupta N, Xu Z, Steed H, Karsan A, Fu Y.
    Cell Signal; 2013 Dec 02; 25(12):2780-7. PubMed ID: 24041655
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A, Daou GB, Srivastava AK.
    Am J Physiol Heart Circ Physiol; 2007 Oct 02; 293(4):H2072-9. PubMed ID: 17644565
    [Abstract] [Full Text] [Related]

  • 5. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK.
    Oncogene; 2006 Apr 06; 25(15):2203-12. PubMed ID: 16288207
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
    Miraglia E, De Angelis F, Gazzano E, Hassanpour H, Bertagna A, Aldieri E, Revelli A, Ghigo D.
    Reproduction; 2011 Jan 06; 141(1):47-54. PubMed ID: 20965947
    [Abstract] [Full Text] [Related]

  • 7. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
    Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T, Edes I, Koller A, Bagi Z.
    Am J Physiol Heart Circ Physiol; 2008 Jun 06; 294(6):H2558-64. PubMed ID: 18408126
    [Abstract] [Full Text] [Related]

  • 8. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
    Monfort P, Muñoz MD, Kosenko E, Felipo V.
    J Neurosci; 2002 Dec 01; 22(23):10116-22. PubMed ID: 12451112
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
    Antonova GN, Snead CM, Antonov AS, Dimitropoulou C, Venema RC, Catravas JD.
    Am J Physiol Heart Circ Physiol; 2007 Feb 01; 292(2):H893-903. PubMed ID: 17012359
    [Abstract] [Full Text] [Related]

  • 10. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
    Newton M, Niewczas I, Clark J, Bellamy TC.
    Anal Biochem; 2010 Jul 15; 402(2):129-36. PubMed ID: 20371357
    [Abstract] [Full Text] [Related]

  • 11. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M, Kolasa T, Chang R, Miller LN, Moreland RB, Brioni JD.
    J Pharmacol Sci; 2006 Oct 15; 102(2):231-8. PubMed ID: 17050951
    [Abstract] [Full Text] [Related]

  • 12. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA, Antunes E, Teixeira CE, De Nucci G.
    Urology; 2008 Sep 15; 72(3):711-5. PubMed ID: 18359064
    [Abstract] [Full Text] [Related]

  • 13. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J.
    Cardiovasc Res; 2007 Oct 01; 76(1):149-59. PubMed ID: 17610859
    [Abstract] [Full Text] [Related]

  • 14. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 15. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C, Kern J, Heitz M, Plas E, Zwerschke W, Mattesich M, Sandner P, Berger P.
    Exp Cell Res; 2015 Nov 01; 338(2):162-9. PubMed ID: 26410556
    [Abstract] [Full Text] [Related]

  • 16. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M, Shimosato T, Iwasaki H, Imamura T, Okamura T.
    J Cardiovasc Pharmacol; 2015 Feb 01; 65(2):160-7. PubMed ID: 25329747
    [Abstract] [Full Text] [Related]

  • 17. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP.
    Br J Pharmacol; 2009 Jul 01; 157(5):781-95. PubMed ID: 19466990
    [Abstract] [Full Text] [Related]

  • 18. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 01; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 19. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.
    Joshi CN, Martin DN, Fox JC, Mendelev NN, Brown TA, Tulis DA.
    J Pharmacol Exp Ther; 2011 Nov 01; 339(2):394-402. PubMed ID: 21825001
    [Abstract] [Full Text] [Related]

  • 20. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G, Dhaese I, Sips P, Buys E, Brouckaert P, Lefebvre RA.
    J Physiol; 2007 Nov 01; 584(Pt 3):907-20. PubMed ID: 17717014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.